I think, to that end, Medvi just showed the future of AI-native distribution
Compounded Semaglutide is a once daily GLP-1 medication that mimics the effect of feeling full by delaying gastric emptying to reduce appetite, improve control of eating and reduce food cravings
Human data is still very limited, including small pilot work such as the knee pain survey of 16 patients, plus a few other early studies and reviews calling out the lack of large, rigorous trials
Exendin-4 (a peptide that shares 53% amino acid sequence with native GLP-1), however, was found to be effective in rat models for preventing 6-OHDA-induced DA-ergic neuron loss and increasing the number of neural stem cells in the subventricular zone ( 3.2.2.2 Clinical studies At the clinical level, RCTs have been carried out to evaluate the effects of some GLP-MA in PD patients (Table 2) (Hlscher, 2024)
It provides no extra benefit but exponentially increases the risk of adverse reactions
It felt when I was initially taking the medicationwhen I was feeling down I felt an initial ability to process and cope better and quicker
